Celularity (CELU) Announces CFO Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Celularity Announces Chief Financial Officer Transition
June 10, 2025 4:15 PM EDTFLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity or the Company), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (CFO), David Beers, effective immediately. Mr. Beers termination was not related to the Companys financial or operating results or to any disagreements or concerns regarding the Companys financial or reporting practices. Mr. Beers was terminated without cause under the terms of his employment agreement dated April 1, 2022, as... More



